The new definition and diagnostic criteria of Parkinson's disease
[...]to account for the long prodromal stage of Parkinson's disease and to set the stage for earlier intervention in the future, the first ever Movement Disorder Society research criteria for prodromal Parkinson's disease were proposed.3 The criteria's approach is unique because it us...
Gespeichert in:
| Veröffentlicht in: | Lancet neurology 2016-05, Vol.15 (6), p.546-548 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 548 |
|---|---|
| container_issue | 6 |
| container_start_page | 546 |
| container_title | Lancet neurology |
| container_volume | 15 |
| creator | Postuma, Ronald B Berg, Daniela Adler, Charles H Bloem, Bastiaan R Chan, Piu Deuschl, Günther Gasser, Thomas Goetz, Christopher G Halliday, Glenda Joseph, Lawrence Lang, Anthony E Liepelt-Scarfone, Inga Litvan, Irene Marek, Kenneth Oertel, Wolfgang Olanow, C Warren Poewe, Werner Stern, Matthew |
| description | [...]to account for the long prodromal stage of Parkinson's disease and to set the stage for earlier intervention in the future, the first ever Movement Disorder Society research criteria for prodromal Parkinson's disease were proposed.3 The criteria's approach is unique because it uses statistical methods (the Bayesian naive classifier) to estimate the likelihood that a patient has prodromal Parkinson's disease. [...]the field of prodromal Parkinson's disease is still in its relative infancy; the method provides a scaffold upon which results of new diagnostic tests for prodromal Parkinson's disease can be continually added. Because the field of Parkinson's disease is constantly evolving, diagnostic methods need to be constantly updated.\n PC received grant support from the Ministry of Science and Technology of China. |
| doi_str_mv | 10.1016/S1474-4422(16)00116-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1797540860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1474442216001162</els_id><sourcerecordid>4023242011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-67d2b1ccaa0e50a25105b3e99a8e215760c32ec3c9cdd655eee997bf4b58e06c3</originalsourceid><addsrcrecordid>eNqFkU1vFSEUhompsR_6E2wm6cJ2McphgJnZaJqmVZMmmljXhDmcsbRzocLcNv33cj-sSTeuOMBzHuCFsbfA3wMH_eEHyFbWUgpxDPqEcwBdixdsb7us1c5TLcQu28_5hnMBsoNXbFe0TakF32OnV9dUBXqoHI0--NnHUNngKuftrxDz7LHC5GdK3lZxrL7bdOtDjuFdLkgmm-k1eznaKdOb7XjAfl6cX519qS-_ff56dnpZo-zVXOvWiQEQreWkuBUKuBoa6nvbkQDVao6NIGywR-e0UkRlrx1GOaiOuMbmgB1vvHcp_l5Sns3CZ6RpsoHiMhto-1ZJ3mle0KNn6E1cplBuV6gOQKoWmkKpDYUp5pxoNHfJL2x6NMDNKmOzztisAjRlts7YiNJ3uLUvhwW5p66_oRbg0wagEse9p2QyegpIzifC2bjo_3vEx2cGnMrvoJ1u6ZHyv9eYLAzfSFYO0GuDaP4AOtKemg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781145713</pqid></control><display><type>article</type><title>The new definition and diagnostic criteria of Parkinson's disease</title><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Postuma, Ronald B ; Berg, Daniela ; Adler, Charles H ; Bloem, Bastiaan R ; Chan, Piu ; Deuschl, Günther ; Gasser, Thomas ; Goetz, Christopher G ; Halliday, Glenda ; Joseph, Lawrence ; Lang, Anthony E ; Liepelt-Scarfone, Inga ; Litvan, Irene ; Marek, Kenneth ; Oertel, Wolfgang ; Olanow, C Warren ; Poewe, Werner ; Stern, Matthew</creator><creatorcontrib>Postuma, Ronald B ; Berg, Daniela ; Adler, Charles H ; Bloem, Bastiaan R ; Chan, Piu ; Deuschl, Günther ; Gasser, Thomas ; Goetz, Christopher G ; Halliday, Glenda ; Joseph, Lawrence ; Lang, Anthony E ; Liepelt-Scarfone, Inga ; Litvan, Irene ; Marek, Kenneth ; Oertel, Wolfgang ; Olanow, C Warren ; Poewe, Werner ; Stern, Matthew</creatorcontrib><description>[...]to account for the long prodromal stage of Parkinson's disease and to set the stage for earlier intervention in the future, the first ever Movement Disorder Society research criteria for prodromal Parkinson's disease were proposed.3 The criteria's approach is unique because it uses statistical methods (the Bayesian naive classifier) to estimate the likelihood that a patient has prodromal Parkinson's disease. [...]the field of prodromal Parkinson's disease is still in its relative infancy; the method provides a scaffold upon which results of new diagnostic tests for prodromal Parkinson's disease can be continually added. Because the field of Parkinson's disease is constantly evolving, diagnostic methods need to be constantly updated.\n PC received grant support from the Ministry of Science and Technology of China.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(16)00116-2</identifier><identifier>PMID: 27302120</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Constipation ; Dementia ; Deposition ; Grants ; Neurology ; Parkinson's disease ; Pharmaceutical industry ; Royalties ; Task forces ; Variables</subject><ispartof>Lancet neurology, 2016-05, Vol.15 (6), p.546-548</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright Elsevier Limited May 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-67d2b1ccaa0e50a25105b3e99a8e215760c32ec3c9cdd655eee997bf4b58e06c3</citedby><cites>FETCH-LOGICAL-c495t-67d2b1ccaa0e50a25105b3e99a8e215760c32ec3c9cdd655eee997bf4b58e06c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1781145713?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,64361,64363,64365,65309,72215</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27302120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Postuma, Ronald B</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Adler, Charles H</creatorcontrib><creatorcontrib>Bloem, Bastiaan R</creatorcontrib><creatorcontrib>Chan, Piu</creatorcontrib><creatorcontrib>Deuschl, Günther</creatorcontrib><creatorcontrib>Gasser, Thomas</creatorcontrib><creatorcontrib>Goetz, Christopher G</creatorcontrib><creatorcontrib>Halliday, Glenda</creatorcontrib><creatorcontrib>Joseph, Lawrence</creatorcontrib><creatorcontrib>Lang, Anthony E</creatorcontrib><creatorcontrib>Liepelt-Scarfone, Inga</creatorcontrib><creatorcontrib>Litvan, Irene</creatorcontrib><creatorcontrib>Marek, Kenneth</creatorcontrib><creatorcontrib>Oertel, Wolfgang</creatorcontrib><creatorcontrib>Olanow, C Warren</creatorcontrib><creatorcontrib>Poewe, Werner</creatorcontrib><creatorcontrib>Stern, Matthew</creatorcontrib><title>The new definition and diagnostic criteria of Parkinson's disease</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>[...]to account for the long prodromal stage of Parkinson's disease and to set the stage for earlier intervention in the future, the first ever Movement Disorder Society research criteria for prodromal Parkinson's disease were proposed.3 The criteria's approach is unique because it uses statistical methods (the Bayesian naive classifier) to estimate the likelihood that a patient has prodromal Parkinson's disease. [...]the field of prodromal Parkinson's disease is still in its relative infancy; the method provides a scaffold upon which results of new diagnostic tests for prodromal Parkinson's disease can be continually added. Because the field of Parkinson's disease is constantly evolving, diagnostic methods need to be constantly updated.\n PC received grant support from the Ministry of Science and Technology of China.</description><subject>Constipation</subject><subject>Dementia</subject><subject>Deposition</subject><subject>Grants</subject><subject>Neurology</subject><subject>Parkinson's disease</subject><subject>Pharmaceutical industry</subject><subject>Royalties</subject><subject>Task forces</subject><subject>Variables</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkU1vFSEUhompsR_6E2wm6cJ2McphgJnZaJqmVZMmmljXhDmcsbRzocLcNv33cj-sSTeuOMBzHuCFsbfA3wMH_eEHyFbWUgpxDPqEcwBdixdsb7us1c5TLcQu28_5hnMBsoNXbFe0TakF32OnV9dUBXqoHI0--NnHUNngKuftrxDz7LHC5GdK3lZxrL7bdOtDjuFdLkgmm-k1eznaKdOb7XjAfl6cX519qS-_ff56dnpZo-zVXOvWiQEQreWkuBUKuBoa6nvbkQDVao6NIGywR-e0UkRlrx1GOaiOuMbmgB1vvHcp_l5Sns3CZ6RpsoHiMhto-1ZJ3mle0KNn6E1cplBuV6gOQKoWmkKpDYUp5pxoNHfJL2x6NMDNKmOzztisAjRlts7YiNJ3uLUvhwW5p66_oRbg0wagEse9p2QyegpIzifC2bjo_3vEx2cGnMrvoJ1u6ZHyv9eYLAzfSFYO0GuDaP4AOtKemg</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Postuma, Ronald B</creator><creator>Berg, Daniela</creator><creator>Adler, Charles H</creator><creator>Bloem, Bastiaan R</creator><creator>Chan, Piu</creator><creator>Deuschl, Günther</creator><creator>Gasser, Thomas</creator><creator>Goetz, Christopher G</creator><creator>Halliday, Glenda</creator><creator>Joseph, Lawrence</creator><creator>Lang, Anthony E</creator><creator>Liepelt-Scarfone, Inga</creator><creator>Litvan, Irene</creator><creator>Marek, Kenneth</creator><creator>Oertel, Wolfgang</creator><creator>Olanow, C Warren</creator><creator>Poewe, Werner</creator><creator>Stern, Matthew</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20160501</creationdate><title>The new definition and diagnostic criteria of Parkinson's disease</title><author>Postuma, Ronald B ; Berg, Daniela ; Adler, Charles H ; Bloem, Bastiaan R ; Chan, Piu ; Deuschl, Günther ; Gasser, Thomas ; Goetz, Christopher G ; Halliday, Glenda ; Joseph, Lawrence ; Lang, Anthony E ; Liepelt-Scarfone, Inga ; Litvan, Irene ; Marek, Kenneth ; Oertel, Wolfgang ; Olanow, C Warren ; Poewe, Werner ; Stern, Matthew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-67d2b1ccaa0e50a25105b3e99a8e215760c32ec3c9cdd655eee997bf4b58e06c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Constipation</topic><topic>Dementia</topic><topic>Deposition</topic><topic>Grants</topic><topic>Neurology</topic><topic>Parkinson's disease</topic><topic>Pharmaceutical industry</topic><topic>Royalties</topic><topic>Task forces</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Postuma, Ronald B</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Adler, Charles H</creatorcontrib><creatorcontrib>Bloem, Bastiaan R</creatorcontrib><creatorcontrib>Chan, Piu</creatorcontrib><creatorcontrib>Deuschl, Günther</creatorcontrib><creatorcontrib>Gasser, Thomas</creatorcontrib><creatorcontrib>Goetz, Christopher G</creatorcontrib><creatorcontrib>Halliday, Glenda</creatorcontrib><creatorcontrib>Joseph, Lawrence</creatorcontrib><creatorcontrib>Lang, Anthony E</creatorcontrib><creatorcontrib>Liepelt-Scarfone, Inga</creatorcontrib><creatorcontrib>Litvan, Irene</creatorcontrib><creatorcontrib>Marek, Kenneth</creatorcontrib><creatorcontrib>Oertel, Wolfgang</creatorcontrib><creatorcontrib>Olanow, C Warren</creatorcontrib><creatorcontrib>Poewe, Werner</creatorcontrib><creatorcontrib>Stern, Matthew</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Postuma, Ronald B</au><au>Berg, Daniela</au><au>Adler, Charles H</au><au>Bloem, Bastiaan R</au><au>Chan, Piu</au><au>Deuschl, Günther</au><au>Gasser, Thomas</au><au>Goetz, Christopher G</au><au>Halliday, Glenda</au><au>Joseph, Lawrence</au><au>Lang, Anthony E</au><au>Liepelt-Scarfone, Inga</au><au>Litvan, Irene</au><au>Marek, Kenneth</au><au>Oertel, Wolfgang</au><au>Olanow, C Warren</au><au>Poewe, Werner</au><au>Stern, Matthew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The new definition and diagnostic criteria of Parkinson's disease</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>15</volume><issue>6</issue><spage>546</spage><epage>548</epage><pages>546-548</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><coden>LANCAO</coden><abstract>[...]to account for the long prodromal stage of Parkinson's disease and to set the stage for earlier intervention in the future, the first ever Movement Disorder Society research criteria for prodromal Parkinson's disease were proposed.3 The criteria's approach is unique because it uses statistical methods (the Bayesian naive classifier) to estimate the likelihood that a patient has prodromal Parkinson's disease. [...]the field of prodromal Parkinson's disease is still in its relative infancy; the method provides a scaffold upon which results of new diagnostic tests for prodromal Parkinson's disease can be continually added. Because the field of Parkinson's disease is constantly evolving, diagnostic methods need to be constantly updated.\n PC received grant support from the Ministry of Science and Technology of China.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27302120</pmid><doi>10.1016/S1474-4422(16)00116-2</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1474-4422 |
| ispartof | Lancet neurology, 2016-05, Vol.15 (6), p.546-548 |
| issn | 1474-4422 1474-4465 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1797540860 |
| source | Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | Constipation Dementia Deposition Grants Neurology Parkinson's disease Pharmaceutical industry Royalties Task forces Variables |
| title | The new definition and diagnostic criteria of Parkinson's disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T06%3A20%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20new%20definition%20and%20diagnostic%20criteria%20of%20Parkinson's%20disease&rft.jtitle=Lancet%20neurology&rft.au=Postuma,%20Ronald%20B&rft.date=2016-05-01&rft.volume=15&rft.issue=6&rft.spage=546&rft.epage=548&rft.pages=546-548&rft.issn=1474-4422&rft.eissn=1474-4465&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1474-4422(16)00116-2&rft_dat=%3Cproquest_cross%3E4023242011%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781145713&rft_id=info:pmid/27302120&rft_els_id=S1474442216001162&rfr_iscdi=true |